Ageing of the heart reversed by youthful systemic factors!

Andrew S Brack1

  • 1Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Harvard Stem Cell Institute, Boston, MA, USA. Brack.Andrew@mgh.harvard.edu

The EMBO Journal
|July 18, 2013
PubMed

Insights

Youthful blood factors, like GDF11, can reverse age-related cardiac hypertrophy in mice. This suggests systemic factors are crucial for maintaining heart health during aging.

Area of Science:

  • Gerontology
  • Cardiovascular Biology
  • Regenerative Medicine

Background:

  • Aging leads to impaired tissue maintenance and repair, with unclear underlying mechanisms.
  • Age-related tissue demise has severe physiological consequences.
  • Cardiac hypertrophy is a common age-associated cardiovascular issue.

Purpose of the Study:

  • To investigate the role of blood-borne factors in age-related cardiac hypertrophy.
  • To identify specific factors contributing to cardiac aging.
  • To explore potential therapeutic interventions for age-related heart conditions.

Main Methods:

  • A study published in Cell (Loffredo et al, 2013) analyzed blood-borne factors in aged mice.
  • Aged mice were exposed to youthful systemic factors.
  • Specific factor GDF11 was administered to aged mice.

Main Results:

  • The study proposes that loss of blood-borne factors during aging contributes to cardiac hypertrophy.
  • Exposure to youthful systemic factors reduced cardiac hypertrophy in aged mice.
  • Administration of GDF11 alone decreased cardiac hypertrophy in aged mice.

Conclusions:

  • Systemic factors present in youthful blood can reverse age-related cardiac hypertrophy.
  • GDF11 is identified as a key blood-borne factor involved in mitigating cardiac aging.
  • This research opens avenues for therapies targeting age-related cardiovascular decline.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...